Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

Devidas MenonDerek Clark and Tania Stafinski

首页> 外文期刊>Healthcare policy >Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

【24h】

Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

机译：通过加拿大的公共卫生系统对罕见病药物的报销：我们现在在哪里？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Healthcare policy》 |2015年第1期|共页
作者
Devidas MenonDerek Clark and Tania Stafinski;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医学、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey [J] . Julie Polisena, Michael Burgess, Craig Mitton, BMC Health Services Research . 2017,第1期

机译：让加拿大公众参与罕见病药物的报销决策：一项全国在线调查
2. Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey [J] . Julie Polisena, Michael Burgess, Craig Mitton, BMC Health Services Research . 2017,第1期

机译：让加拿大公众参与罕见病药物的报销决策：一项全国在线调查
3. A National Approach to Reimbursement Decision-Making on Drugs for Rare Diseases in Canada? Insights from Across the Ponds [J] . Hilary ShortTania Stafinski and Devidas Menon Healthcare policy . 2015,第4期

机译：在加拿大对罕见病药物进行报销决策的国家方法？跨池塘的见解
4. Application of the Forgotten Effects Model to the Economic Effects for Public European Health Systems by the Early Diagnostics of Emergent and Rare Diseases [C] . Anna Maria Gil-Lafuente International Conference Economic Scientific Research: Theoretical, Empirical and Practical Approaches . 2015

机译：遗忘效应模型在兴兴疾病早期诊断下诊断遗产造成欧洲卫生系统的经济影响
5. Hospital health care executives' attitudes and beliefs on the impact that the Healthcare Providers and Systems survey has on service quality and hospital reimbursement. [D] . Billiter, Patrick Flanagan. 2011

机译：医院医疗保健主管对“医疗保健提供者和系统”调查对服务质量和医院报销的影响的态度和信念。
6. Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now? [O] . Devidas Menon, Derek Clark, Tania Stafinski 2015

机译：通过加拿大的公共卫生系统对罕见病药物的报销：我们现在在哪里？
7. Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now? [O] . Devidas Menon, Derek Clark, Tania Stafinski 2015

机译：通过加拿大公共医疗保健系统偿还罕见疾病的药物：我们现在在哪里？

Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

著录项

相似文献

相关主题

期刊订阅